Hypereosinophilic syndrome: The hypereosinophilic syndrome (HES) is a disease characterized by a persistently elevated eosinophil count (≥ 1500 eosinophils/mm³) in the blood for at least six months without any recognizable cause, with involvement of either the heart, nervous system, or bone marrow. HES is a diagnosis of exclusion, after clonal eosinophilia (such as leukemia) and reactive eosinophilia (in response to infection, autoimmune disease, atopy, hypoadrenalism, tropical eosinophilia, or cancer) have been ruled out.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1943 |
4. Check minimum number of eventsNone |
1943 |
5. Include endpoints |
2064 |
6. Filter based on genotype QC (FinnGen only) |
2064 |
Control definitions (FinnGen only)
- Control exclude
- D3_BLOODOTHER
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D70-D77
- Name in latin
- Aliae morbositates leucocytorum
Similar endpoints
↥List of similar endpoints to
Other disorders of white blood cells
based on the number of shared cases.
Similar with more cases:
- Other diseases of blood and blood-forming organs, wide
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 15172 | 7959 | 7095 |
| Only index persons | 12791 | 6804 | 5987 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.21 | 0.23 | 0.20 |
| Only index persons | 0.24 | 0.25 | 0.23 |
| Median age at first event (years) | |||
| Whole population | 58.28 | 57.40 | 59.16 |
| Only index persons | 56.26 | 54.92 | 57.78 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2064 | 1100 | 964 |
| Unadjusted period prevalence (%) | 0.40 | 0.37 | 0.42 |
| Median age at first event (years) | 56.57 | 52.19 | 61.56 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1886
- Matched controls
- 18860
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D72.1
ICD-10 Finland
Eosinophilia
6387.5
323.0
491
*
XW000
NOMESCO Finland
Bone marrow biopsy
26.7
323.0
518
263
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
2087.8
323.0
1083
12
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
599.3
268.3
260
5
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
14.6
187.1
329
268
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
41.1
173.6
219
60
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.5
118.2
485
1339
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
48.4
107.6
131
29
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
104.0
1056
5751
D70.89
ICD-10 Finland
Neutropenic splenomegaly
464.1
90.0
89
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
22.2
79.3
117
56
H02AB06
ATC
prednisolone; systemic
2.4
72.7
1018
6150
2888B
ICD-9 Finland
Diseases of white blood cells, Other specified disease of white blood cells[LEUCOPENIA]
+∞
72.3
69
*
R50.9
ICD-10 Finland
Fever, unspecified
3.2
66.6
399
1439
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
94.9
66.4
73
8
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
59.5
569
2732
L01XX05
ATC
hydroxycarbamide; oral
17.8
55.1
87
51
M04AA01
ATC
allopurinol; systemic
3.0
52.7
342
1283
J45.9
ICD-10 Finland
Asthma, unspecified
2.6
50.2
421
1850
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
47.8
292
1047
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
46.7
667
3806
189
Kela drug reimbursment
Imatinib
38.0
46.5
59
16
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.0
45.9
195
523
J01MA12
ATC
levofloxacin; systemic
2.5
45.6
431
2010
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.3
44.8
175
434
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
48.5
43.1
52
11
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
51.3
41.8
50
10
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
9.8
40.9
84
89
A02BC02
ATC
pantoprazole; systemic
1.9
40.6
1229
9239
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.2
40.2
235
810
ZXE00
NOMESCO Finland
One hour or less
2.0
40.1
808
5221
JN4BD
NOMESCO Finland
Extensive body CT
2.8
40.0
284
1116
L01XE01
ATC
[U] imatinib; oral
36.6
39.2
50
14
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.9
39.1
262
991
WW500
NOMESCO Finland
Blood transfusion
5.0
39.0
132
282
D70.82
ICD-10 Finland
Drug-induced neutropenia
104.7
37.9
41
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
37.6
589
3425
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.7
37.3
172
494
L03AA02
ATC
filgrastim; parenteral
5.9
36.6
106
189
J32.4
ICD-10 Finland
Chronic pansinusitis
9.2
34.0
72
81
H02AB09
ATC
hydrocortisone; systemic
6.6
33.9
90
143
R03BB04
ATC
tiotropium bromide; inhalant
2.7
33.8
249
995
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.1
33.2
200
702
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
75.6
32.9
37
5
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
32.7
976
7048
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
15.0
32.4
54
37
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
62.8
32.1
37
6
J45.1
ICD-10 Finland
Nonallergic asthma
3.2
31.8
179
598
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
115.4
31.8
34
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
48.4
31.6
38
8
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.1
30.6
405
2169
D64.9
ICD-10 Finland
Anaemia, unspecified
2.7
30.0
224
900
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
29.7
431
2392
J01MA14
ATC
moxifloxacin; systemic
2.8
29.6
211
821
R03AC02
ATC
salbutamol; inhalant
1.7
28.8
972
7176
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.8
28.4
201
781
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
39.6
28.1
35
9
R03DC03
ATC
montelukast; oral
2.2
28.0
328
1656
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.3
27.9
106
255
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
27.9
323
1624
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.9
27.7
183
681
J01DB01
ATC
cefalexin; oral
1.9
27.5
1518
12951
C03CA01
ATC
furosemide; systemic
1.9
27.5
546
3390
TGC00
NOMESCO Finland
Bronchial lavation
5.3
27.5
86
169
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.7
27.3
125
356
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
27.3
700
4727
D72.0
ICD-10 Finland
Genetic anomalies of leukocytes
+∞
27.1
26
*
C91.7
ICD-10 Finland
Other lymphoid leukaemia
76.3
26.8
30
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.4
26.8
99
232
Z3231
NOMESCO Finland
Registered nurse
1.8
26.7
543
3391
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.8
26.6
187
722
ZX120
NOMESCO Finland
Intravenous
2.6
26.3
214
899
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
73.7
25.8
29
*
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
28.8
25.4
34
12
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
70.9
24.8
28
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
23.7
24.8
35
15
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
24.4
352
1932
R03AK08
ATC
formoterol and beclometasone; inhalant
4.0
24.4
102
269
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.4
24.1
213
935
127
Kela drug reimbursment
Transplant complication
6.6
24.0
62
96
Z2221
NOMESCO Finland
Medical doctor
1.8
23.1
532
3432
ZX112
NOMESCO Finland
Subcutaneous
5.2
22.7
71
140
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
22.5
512
3285
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
22.5
418
2512
WW200
NOMESCO Finland
Immunization
4.2
22.3
86
211
316
Kela drug reimbursment
Imatinib
52.7
22.1
26
5
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
22.0
405
2422
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.6
21.5
100
289
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
4.7
21.4
74
163
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
3.0
21.0
128
452
A41.9
ICD-10 Finland
Sepsis, unspecified
3.7
20.8
93
261
L01BB05
ATC
fludarabine; systemic
77.7
20.7
23
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
20.7
387
2320
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
18.5
20.4
31
17
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
20.4
196
895
A04AA01
ATC
ondansetron; systemic, rectal
2.7
20.4
144
558
H02AB07
ATC
prednisone; oral
2.0
20.1
278
1490
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
20.1
733
5342
JN4AD
NOMESCO Finland
Body CT examination
2.5
20.0
164
688
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.7
19.7
140
543
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
74.3
19.7
22
*
152
Kela drug reimbursment
Nilotinib
106.1
19.6
21
*
XG474
NOMESCO Finland
Exhalation nntrogen oxide
4.1
19.5
77
194
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
4.0
19.4
80
209
A02BC01
ATC
omeprazole; systemic
1.7
19.0
516
3462
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
19.0
614
4320
B73
ICPC
Leukaemia
34.7
18.9
24
7
H02AB04
ATC
methylprednisolone; systemic
2.0
18.7
270
1470
R06.0
ICD-10 Finland
Dyspnoea
1.7
18.6
454
2951
R03BA05
ATC
fluticasone; inhalant
1.8
18.4
329
1938
J33.0
ICD-10 Finland
Polyp of nasal cavity
3.8
18.3
78
210
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.3
18.3
176
806
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
19.5
18.2
27
14
R4110
NOMESCO Finland
Physiotherapy
1.7
18.0
480
3195
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
53.0
18.0
21
*
E0000UV
ATC
NA
1.6
17.7
690
5064
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.7
17.7
121
459
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
17.7
171
782
Z3226
NOMESCO Finland
Physiotherapist
1.8
17.6
347
2106
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.6
17.6
137
561
J01FF01
ATC
clindamycin; systemic
1.7
17.5
479
3208
J01AA02
ATC
doxycycline; systemic
1.6
17.5
1382
11954
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.6
17.4
127
501
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
17.4
281
1593
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
17.4
307
1796
J01CA04
ATC
amoxicillin; systemic
1.6
17.3
1442
12616
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
17.3
328
1963
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
17.2
309
1821
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
17.0
371
2323
D75.2
ICD-10 Finland
Essential thrombocytosis
63.9
16.8
19
*
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
16.3
259
1459
L04AD01
ATC
ciclosporin; systemic
4.3
16.1
59
139
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.6
16.0
118
468
J05AB11
ATC
valaciclovir; oral
1.9
15.8
232
1267
2888A
ICD-9 Finland
Diseases of white blood cells, Other specified disease of white blood cells[LEUCOCYTOSIS]
+∞
15.6
15
*
UJF32
NOMESCO Finland
Coloscopy
1.6
15.5
447
3021
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
15.4
370
2376
J01FA09
ATC
clarithromycin; systemic
1.6
15.4
533
3774
N02AX02
ATC
tramadol; systemic, rectal
1.5
15.3
739
5652
1512
Kela drug reimbursment
Ibrutinib
28.8
15.2
20
7
R06AE07
ATC
cetirizine; oral
1.5
15.1
745
5717
WX110
NOMESCO Finland
Local anesthesy
1.5
15.1
1194
10121
N02BE01
ATC
paracetamol; systemic, rectal
1.6
15.1
1530
13729
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
15.0
305
1860
A46
ICD-10 Finland
Erysipelas
1.8
15.0
257
1484
Z2446
NOMESCO Finland
Social worker
2.3
15.0
138
616
L04AA06
ATC
mycophenolic acid; systemic
4.6
14.9
51
113
390
Kela drug reimbursment
Ibrutinib
25.2
14.7
20
8
A05AA02
ATC
ursodeoxycholic acid; oral
4.7
14.6
49
106
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.1
14.6
56
139
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.1
14.4
172
866
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
4.8
14.4
47
99
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
12.6
14.4
25
20
J01MA02
ATC
ciprofloxacin; systemic
1.5
14.4
666
5028
212
Kela drug reimbursment
Gout
4.4
14.3
51
118
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.2
14.3
75
241
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
3.1
14.1
76
249
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
10.1
14.0
27
27
R53
ICD-10 Finland
Malaise and fatigue
1.7
13.9
349
2264
B03XA02
ATC
darbepoetin alfa; parenteral
4.4
13.9
50
117
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
13.8
204
1116
R03BA08
ATC
ciclesonide; inhalant
2.1
13.8
152
739
R05
ICD-10 Finland
Cough
1.7
13.8
334
2146
WX402
NOMESCO Finland
General anaesthesia
1.7
13.7
281
1716
ZXD05
NOMESCO Finland
Urgent procedure
1.5
13.7
543
3946
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
13.6
702
5402
D07AC01
ATC
betamethasone; topical
1.5
13.6
577
4257
L01XX28
ATC
[D] imatinib; oral
75.7
13.6
15
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
13.5
200
1095
J46
ICD-10 Finland
Status asthmaticus
3.5
13.5
64
190
150
Kela drug reimbursment
Dasatinib
34.3
13.5
17
5
N06AX16
ATC
venlafaxine; oral
1.8
13.5
230
1323
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
13.4
250
1479
WX892
NOMESCO Finland
Monitored bed care
2.1
13.4
147
714
XQ800
NOMESCO Finland
Prick test
2.2
13.3
138
654
A02BC05
ATC
esomeprazole; systemic
1.5
13.3
670
5129
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
13.3
286
1772
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
40.4
13.2
16
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.9
13.1
196
1075
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
7.9
13.1
29
37
P01AB01
ATC
metronidazole; oral, rectal
1.5
13.0
647
4932
J45.8
ICD-10 Finland
Mixed asthma
3.2
12.9
68
220
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
12.9
134
636
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.9
12.9
183
988
L01XE06
ATC
[U] dasatinib; systemic
50.3
12.8
15
*
A07AA02
ATC
nystatin; oral
2.3
12.8
126
580
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.1
12.8
49
122
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
12.8
565
4199
WX002
NOMESCO Finland
Sedation and analgesia
1.6
12.8
336
2204
R03AK11
ATC
formoterol and fluticasone; inhalant
3.5
12.7
58
168
R01AD08
ATC
fluticasone; nasal
1.5
12.6
473
3385
N05CF01
ATC
zopiclone; oral
1.5
12.6
533
3920
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.4
12.6
106
454
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.1
12.6
68
224
D07AB08
ATC
desonide; topical
1.9
12.5
184
1005
R03DX09
ATC
mepolizumab; parenteral
+∞
12.5
12
*
2883X
ICD-9 Finland
Diseases of white blood cells, Eosinophilia[EOSINOPHILIA, NUD]
+∞
12.5
12
*
3028
Kela drug reimbursment
Mepolizumab
130.8
12.4
13
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.4
12.4
102
433
N03AX16
ATC
pregabalin; oral
1.6
12.3
394
2713
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
11.7
12.3
22
19
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
12.3
768
6103
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
37.8
12.2
15
*
399
Kela drug reimbursment
Venetoclax
37.8
12.2
15
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
18.2
12.0
18
10
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
26.9
12.0
16
6
L01AA01
ATC
cyclophosphamide; systemic
11.1
12.0
22
20
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
12.0
154
796
ZX108
NOMESCO Finland
Inhalation
7.3
12.0
28
39
ZXA10
NOMESCO Finland
Bilateral
1.6
12.0
321
2110
L01AA02
ATC
chlorambucil; oral
13.5
11.9
20
15
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
11.9
220
1298
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.1
11.9
65
216
DHB20
NOMESCO Finland
Polypectomy of internal nose
4.6
11.9
40
88
L01XX52
ATC
venetoclax; oral
47.0
11.9
14
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
4.1
11.8
45
112
L03AA13
ATC
pegfilgrastim; parenteral
3.0
11.8
67
226
AA1AD
NOMESCO Finland
CT of head and brain
1.6
11.7
396
2760
XF600
NOMESCO Finland
Bloodpressure measurement
2.2
11.7
122
580
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
4.9
11.7
37
76
ZY010
NOMESCO Finland
Hospital outpatient
2.5
11.7
89
362
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
7.4
11.7
27
37
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
3.7
11.7
50
138
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
23.0
11.6
16
7
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
11.5
448
3220
SPAT1254
SPAT
Administration of medicine
1.7
11.5
256
1597
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.4
11.5
97
418
297
Kela drug reimbursment
NA
120.7
11.4
12
*
R01AD09
ATC
mometasone; nasal
1.4
11.4
738
5882
R02
ICPC
Shortness of breath/dyspnoea
1.8
11.4
207
1217
L04AX01
ATC
azathioprine; systemic
2.5
11.3
86
349
XX3DW
NOMESCO Finland
Time consuming IT work
1.9
11.3
178
993
7806A
ICD-9 Finland
General symptoms, Pyrexia of unknown origin
7.0
11.3
27
39
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.7
11.2
74
276
SPAT1262
SPAT
Handing over of treatment supplies
1.6
11.2
312
2072
WZC30
NOMESCO Finland
Teaching
1.7
11.2
221
1332
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
11.2
108
496
R96
ICPC
Asthma
2.0
11.2
150
792
N02AA05
ATC
oxycodone; systemic
1.7
11.2
240
1485
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.2
11.1
110
511
SPAT1263
SPAT
Sampling
1.4
11.0
721
5747
D45
ICD-10 Finland
Polycythaemia vera
5.6
11.0
31
56
R01AD12
ATC
fluticasone furoate; nasal
1.5
11.0
469
3437
R03AK07
ATC
formoterol and budesonide; inhalant
1.6
10.9
310
2065
GD1AD
NOMESCO Finland
Thorax CT examination
2.5
10.9
86
355
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.8
10.9
69
253
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.7
10.9
73
277
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
10.8
306
2036
R60.0
ICD-10 Finland
Localized oedema
1.8
10.8
183
1050
N05BA01
ATC
diazepam; systemic, rectal
1.7
10.7
226
1387
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
21.6
10.7
15
7
J45
ICD-10 Finland
Asthma
1.9
10.7
162
897
L01XE08
ATC
[U] nilotinib; oral
60.3
10.6
12
*
RS220
NOMESCO Finland
NA
4.7
10.6
35
76
B99
ICPC
Blood/lymph/spleen disease other
10.6
10.3
19
18
J01FA10
ATC
azithromycin; systemic
1.4
10.3
960
8110
J02AC03
ATC
voriconazole; systemic
18.9
10.3
15
8
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.3
10.2
94
425
C83.1
ICD-10 Finland
Mantle cell lymphoma
13.2
10.2
17
13
B01AB10
ATC
tinzaparin; parenteral
2.0
10.1
123
624
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
11.3
10.1
18
16
D07AA02
ATC
hydrocortisone; topical
1.7
10.0
216
1335
XG410
NOMESCO Finland
Flow-volume spirometry
2.4
10.0
84
362
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
40.3
10.0
12
*
JN6AD
NOMESCO Finland
CT of torso and neck
4.9
9.9
31
64
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
9.9
197
1192
L01EL01
ATC
ibrutinib; oral
26.2
9.8
13
5
120
Kela drug reimbursment
Hypogammaglobulinaemia
26.2
9.8
13
5
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
9.8
444
3285
L01XE27
ATC
[U] ibrutinib; oral
20.1
9.8
14
7
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.2
9.7
101
481
C07AB07
ATC
bisoprolol; oral
1.4
9.6
773
6340
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.6
9.6
69
273
N05BA04
ATC
oxazepam; oral
1.5
9.6
403
2935
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
9.5
197
1206
A41.8
ICD-10 Finland
Other specified sepsis
4.0
9.4
36
91
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
9.4
280
1886
L01EA03
ATC
nilotinib; oral
100.5
9.4
10
*
328
Kela drug reimbursment
Nilotinib
100.5
9.4
10
*
M05BA04
ATC
alendronic acid; oral
1.9
9.4
138
752
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
30.2
9.4
12
*
D75.1
ICD-10 Finland
Secondary polycythaemia
17.6
9.4
14
8
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
17.6
9.4
14
8
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.7
9.3
39
107
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
9.6
9.3
18
19
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.9
9.2
133
723
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.0
9.2
110
556
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
13.7
9.2
15
11
N03AE01
ATC
clonazepam; systemic
2.1
9.1
101
494
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
9.1
86
394
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.8
9.0
55
199
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
9.0
227
1467
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
3.3
9.0
44
137
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.0
9.0
111
569
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.8
9.0
144
812
J01DA01
ATC
[U] cefalexin; systemic
1.3
8.9
1038
8992
K59.1
ICD-10 Finland
Functional diarrhoea
2.2
8.9
88
412
B02.9
ICD-10 Finland
Zoster without complication
2.1
8.8
96
466
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
8.8
363
2627
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
10.7
8.8
16
15
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.2
8.8
84
387
L01BB02
ATC
mercaptopurine; oral
6.0
8.8
23
39
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
8.7
205
1298
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.0
8.7
106
539
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
4.0
8.6
33
84
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.0
8.6
112
583
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.9
8.6
34
89
S18
ICPC
Laceration/cut
1.4
8.6
679
5521
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
8.6
177
1078
J02AC01
ATC
fluconazole; systemic
1.4
8.6
615
4926
A28
ICPC
Limited function/disability NOS
1.6
8.6
233
1534
9101
FHL
Bone biopsy
16.4
8.5
13
8
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
7.0
8.5
20
29
S97
ICPC
Chronic ulcer skin
2.1
8.5
97
482
J47
ICD-10 Finland
Bronchiectasis
3.4
8.5
40
121
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
3.7
8.5
35
95
B01AB05
ATC
enoxaparin; parenteral
1.4
8.5
483
3717
R03AC12
ATC
salmeterol; inhalant
2.2
8.5
82
378
L28
ICPC
Limited function/disability (L)
1.6
8.5
247
1653
R11
ICD-10 Finland
Nausea and vomiting
1.9
8.5
131
730
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
20.1
8.5
12
6
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.1
8.4
89
428
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
8.4
215
1393
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
90.4
8.4
9
*
D72
ICD-10 Finland
Other disorders of white blood cells
90.4
8.4
9
*
T90
ICPC
Diabetes non-insulin dependent
1.5
8.4
362
2645
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.1
8.4
44
145
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
8.4
116
621
D73.1
ICD-10 Finland
Hypersplenism
+∞
8.3
8
*
3027
Kela drug reimbursment
Benralizumab
+∞
8.3
8
*
N06AB04
ATC
citalopram; systemic
1.5
8.3
344
2487
R4120
NOMESCO Finland
Occupational therapy
2.0
8.3
108
567
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
8.2
169
1031
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.0
8.2
101
519
1XC02
NOMESCO Finland
NA
6.5
8.2
20
31
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.9
8.2
126
700
E000001
ATC
NA
1.5
8.2
333
2404
J01FA06
ATC
roxithromycin; oral
1.4
8.1
637
5167
1518
Kela drug reimbursment
NA
33.5
8.1
10
*
L04AA01
ATC
[U] ciclosporin; systemic
3.5
8.1
35
100
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
9.0
8.0
16
18
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.8
8.0
141
818
B01AA03
ATC
warfarin; systemic
1.5
8.0
323
2323
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.9
8.0
111
594
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.7
7.9
149
883
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.4
7.9
67
290
N03AX12
ATC
gabapentin; oral
1.6
7.9
233
1562
J20
ICD-10 Finland
Acute bronchitis
1.7
7.9
149
888
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
7.9
157
950
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
7.8
629
5119
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.7
7.8
161
982
C03DA01
ATC
spironolactone; oral
1.7
7.8
174
1087
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.2
7.7
77
364
ED1AA
NOMESCO Finland
Mandipular X-ray examination
7.4
7.7
17
23
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.7
7.7
150
901
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.9
7.7
101
533
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
7.7
126
719
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.9
7.6
116
643
N06AX11
ATC
mirtazapine; oral
1.4
7.6
484
3787
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
7.6
112
616
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
25.1
7.6
10
*
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
3.7
7.6
31
85
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
3.8
7.6
30
80
SPAT1255
SPAT
Intravenous administration of medicine
1.9
7.5
108
588
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.1
7.5
83
410
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
3.9
7.5
29
76
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
4.4
7.4
25
57
L29.9
ICD-10 Finland
Pruritus, unspecified
2.9
7.4
43
151
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.9
7.4
41
141
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
13.4
7.4
12
9
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
3.7
7.4
30
82
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.0
7.4
90
461
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
7.3
96
503
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
7.3
362
2708
C91
ICD-10 Finland
Lymphoid leukaemia
+∞
7.3
7
*
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
+∞
7.3
7
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.3
7.3
34
104
N05CD07
ATC
temazepam; oral
1.6
7.2
195
1279
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
5.2
7.2
21
41
B82
ICPC
Anaemia other/unspecified
2.8
7.2
43
155
N06AX21
ATC
duloxetine; oral
1.6
7.2
165
1039
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.6
7.1
168
1065
C91.4
ICD-10 Finland
Hairy-cell leukaemia
30.1
7.1
9
*
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
30.1
7.1
9
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
30.1
7.1
9
*
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
30.1
7.1
9
*
324
Kela drug reimbursment
Dasatinib
20.1
7.1
10
5
DPA30
NOMESCO Finland
Sphenotomy
5.0
7.1
21
42
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
12.1
7.1
12
10
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.8
7.1
42
151
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.4
7.1
56
236
N06AA10
ATC
nortriptyline; systemic
3.0
7.0
38
129
R55
ICD-10 Finland
Syncope and collapse
1.6
7.0
170
1085
103
Kela drug reimbursment
Diabetes, insulin-treated
1.4
7.0
412
3173
N05AA02
ATC
levomepromazine; systemic
2.1
7.0
74
356
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
7.0
577
4691
ZXA05
NOMESCO Finland
Left side
1.4
7.0
398
3051
UDC00
NOMESCO Finland
Ear microscopy
1.8
7.0
120
695
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
2.7
7.0
45
169
G47.3
ICD-10 Finland
Sleep apnoea
1.4
7.0
319
2347
F20.9
ICD-10 Finland
Schizophrenia, unspecified
3.0
7.0
38
130
R03BA01
ATC
beclometasone; inhalant
1.5
7.0
220
1501
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
5.2
6.9
20
39
A01AB09
ATC
miconazole; local oral
1.7
6.9
140
852
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
7.5
6.9
15
20
N03AX09
ATC
lamotrigine; oral
2.1
6.9
74
362
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
3.8
6.9
27
72
J33.8
ICD-10 Finland
Other polyp of sinus
2.7
6.9
44
164
N05AH04
ATC
quetiapine; oral
1.5
6.9
244
1708
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.7
6.9
45
172
A02BC03
ATC
lansoprazole; oral
1.4
6.8
448
3513
TAB00
NOMESCO Finland
Lumbar puncture
2.0
6.8
78
391
M81.4
ICD-10 Finland
Drug-induced osteoporosis
8.3
6.8
14
17
R06.2
ICD-10 Finland
Wheezing
2.1
6.8
73
356
J05AB01
ATC
aciclovir; systemic
1.4
6.8
318
2350
UJF92
NOMESCO Finland
Capsular endoscopy
2.9
6.8
39
136
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
9.3
6.8
13
14
6BA02
NOMESCO Finland
NA
9.3
6.8
13
14
C08CA01
ATC
amlodipine; oral
1.3
6.8
549
4452
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
6.8
376
2869
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
40.2
6.8
8
*
R03DC01
ATC
zafirlukast; oral
3.1
6.7
35
116
P01BA02
ATC
hydroxychloroquine; oral
1.7
6.7
125
742
T78.4
ICD-10 Finland
Allergy, unspecified
2.1
6.7
70
337
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.8
6.7
114
657
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.1
6.7
75
373
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
6.7
95
516
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
22.6
6.7
9
*
N05AH02
ATC
clozapine; systemic
3.0
6.7
36
123
A06AD11
ATC
lactulose; oral
1.5
6.6
219
1509
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.9
6.6
91
490
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
5.5
6.6
18
33
M10.9
ICD-10 Finland
Gout, unspecified
1.9
6.6
98
542
R03DA04
ATC
theophylline; systemic, rectal
1.9
6.5
84
441
D11
ICPC
Diarrhoea
1.6
6.5
154
980
A03
ICPC
Fever
1.5
6.5
237
1668
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.1
6.5
71
350
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.3
6.5
58
260
H65.3
ICD-10 Finland
Chronic mucoid otitis media
2.7
6.5
40
149
R03AC13
ATC
formoterol; inhalant
1.9
6.4
83
436
9831/3-C42.1
ICD-O-3
T-cell large granular lymphocytic leukemia of bone marrow
70.1
6.4
7
*
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.1
6.4
68
331
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.7
6.4
127
769
N05BA06
ATC
lorazepam; systemic, sublingual
2.0
6.4
81
423
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.7
6.4
20
43
R06AX27
ATC
desloratadine; oral
1.4
6.4
399
3100
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
6.4
130
792
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
14.4
6.4
10
7
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
14.4
6.4
10
7
9109
FHL
Other measure in this category
14.4
6.4
10
7
M13.9
ICD-10 Finland
Arthritis, unspecified
1.8
6.4
104
593
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.7
6.4
125
755
-50
ICPC
Medication/prescr/renewal
2.1
6.4
67
324
GD1LA
NOMESCO Finland
GD
3.3
6.4
29
88
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
6.3
178
1181
XG405
NOMESCO Finland
Education on PEF monitoring
3.2
6.3
31
99
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.2
6.3
60
278
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.5
6.3
45
180
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.3
6.3
52
226
Z2445
NOMESCO Finland
Psychologist
2.1
6.3
67
326
D07AD01
ATC
clobetasol; topical
1.5
6.3
229
1611
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.1
6.3
65
314
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
3.8
6.3
24
63
N18.8
ICD-10 Finland
Other chronic renal failure
2.4
6.3
48
200
9875/3-C42.1
ICD-O-3
Chronic myelogenous leukemia, BCR/ABL positive of bone marrow
+∞
6.3
6
*
I42.3
ICD-10 Finland
Endomyocardial (eosinophilic) disease
+∞
6.3
6
*
R03DX10
ATC
benralizumab; systemic
+∞
6.3
6
*
2888X
ICD-9 Finland
Diseases of white blood cells, Other specified disease of white blood cells[LEUCOCYTOPATHIA ALIA DEFINITA]
+∞
6.3
6
*
D73.5
ICD-10 Finland
Infarction of spleen
+∞
6.3
6
*
251
Kela drug reimbursment
NA
+∞
6.3
6
*
K02.1
ICD-10 Finland
Caries of dentine
1.3
6.2
890
7767
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
3.4
6.2
28
84
L04AA10
ATC
sirolimus; oral
26.8
6.2
8
*
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
26.8
6.2
8
*
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.0
6.2
79
412
3AC01
NOMESCO Finland
NA
4.1
6.2
22
54
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.4
6.2
50
213
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.7
6.2
111
655
C01CA24
ATC
epinephrine; parenteral
1.8
6.1
91
504
I51.4
ICD-10 Finland
Myocarditis, unspecified
5.8
6.1
16
28
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
6.1
258
1867
B01AB04
ATC
dalteparin; parenteral
2.0
6.1
75
388
R95
ICPC
Chron obstructive pulmonary disease
2.5
6.1
45
185
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
6.1
870
7586
Z3229
NOMESCO Finland
Other healthcare associate professional
1.6
6.1
137
860
B03XA01
ATC
erythropoietin; parenteral
4.0
6.1
22
55
R31
ICD-10 Finland
Unspecified haematuria
1.6
6.1
157
1019
J33.9
ICD-10 Finland
Nasal polyp, unspecified
3.9
6.1
23
60
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.2
6.1
56
258
ZXA00
NOMESCO Finland
Right side
1.3
6.1
418
3301
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
6.1
157
1024
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
4.9
6.0
18
37
DHA10
NOMESCO Finland
Biopsy of cavity of nose
4.9
6.0
18
37
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.1
6.0
67
332
E000002
ATC
NA
1.5
6.0
176
1180
WZA10
NOMESCO Finland
Long statement of health and health related matters
3.5
6.0
26
76
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494434) Karyotype in Bone marrow
262
147
20.27
307.65
1.2
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
857
1864
7.15
307.65
8.4
3.8
u/l
250.1
247.2
0.12
822
1768
(3042111) Morphology [Interpretation] in Bone marrow Narrative
331
241
16.17
307.65
1.8
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
264
147
20.45
307.65
1.3
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1391
5698
5.42
301.62
13.9
5.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
602
1256
6.35
289.88
3.7
2.7
g/l
9.5
10.7
6.15
548
1145
(3027945) Reticulocytes/100 erythrocytes in Blood
744
1885
5.61
289.35
5.0
2.5
%
1.8
1.8
0.41
693
1679
(3023520) Reticulocytes [#/volume] in Blood
601
1395
5.67
255.07
5.4
2.6
e9/l
71.3
69.7
0.43
465
1064
(3022096) Basophils/100 leukocytes in Blood
1551
7613
5.17
249.07
14.8
5.8
%
0.7
0.7
0.06
1500
7107
(3019069) Monocytes/100 leukocytes in Blood
1581
7878
5.30
248.87
15.8
6.1
%
8.4
8.6
1.45
1527
7382
(3006504) Eosinophils/100 leukocytes in Blood
1577
7846
5.28
248.64
15.1
5.8
%
3.6
2.8
9.12
1522
7307
(3002030) Lymphocytes/100 leukocytes in Blood
1594
8094
5.26
241.96
15.2
5.9
%
33.3
27.7
25.93
1528
7555
(3028026) IgM [Mass/volume] in Serum or Plasma
483
980
6.13
236.10
2.1
1.8
g/l
1.4
1.4
0.07
431
901
(3017181) Myelocytes/100 leukocytes in Blood
568
1343
5.46
234.40
8.2
3.9
%
0.6
0.8
1.20
308
383
(3018010) Neutrophils/100 leukocytes in Blood
1558
7981
4.88
227.98
14.0
5.7
%
51.3
57.4
34.63
1497
7478
(3002179) Metamyelocytes/100 leukocytes in Blood
525
1215
5.45
221.05
8.1
3.7
%
0.4
0.5
1.53
253
274
(3006315) Basophils [#/volume] in Blood
1583
8411
4.78
214.91
13.6
5.7
e9/l
0.1
0.0
1.39
1459
7263
(3001604) Monocytes [#/volume] in Blood
1573
8382
4.69
211.02
13.6
5.7
e9/l
0.7
0.6
8.50
1443
7228
(3021440) Promyelocytes/100 leukocytes in Blood
527
1277
5.20
209.50
8.4
4.0
%
0.1
0.1
1.51
299
352
(3013115) Eosinophils [#/volume] in Blood
1603
8703
4.77
208.42
15.2
5.9
e9/l
0.3
0.2
23.68
1488
7625
(3019198) Lymphocytes [#/volume] in Blood
1589
8621
4.66
205.49
13.8
5.7
e9/l
4.7
1.9
13.24
1490
7586
(3025159) Blasts/100 leukocytes in Blood
491
1197
5.07
192.60
8.2
4.1
%
0.2
0.6
0.55
260
295
(3004809) Band form neutrophils/100 leukocytes in Blood
224
250
9.93
185.83
6.0
3.0
%
0.8
1.3
1.02
188
200
(3011412) CD3 cells [#/volume] in Blood
169
139
13.15
172.26
3.3
2.4
e9/l
1.2
1.1
0.43
99
84
(3000093) Morphology [Interpretation] in Blood Narrative
167
137
13.17
170.47
1.2
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1631
9766
4.19
165.10
19.6
8.6
e9/l
4.5
4.1
4.28
1534
8524
(3009445) Proteinase 3 Ab [Units/volume] in Serum
335
695
5.56
156.55
1.5
1.5
u/ml
3.3
14.6
—
7
18
(3004588) Protein electrophoresis panel - Serum or Plasma
433
1121
4.62
155.46
2.1
2.6
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
153
127
12.93
154.88
2.9
2.0
%
34.1
44.0
1.22
24
16
(3020630) Protein [Mass/volume] in Serum or Plasma
481
1363
4.30
153.32
2.2
2.8
g/l
66.0
66.4
0.38
444
1250
(3005322) IgE [Units/volume] in Serum or Plasma
401
1014
4.67
147.88
2.3
1.3
u/ml
526.8
222.2
2.38
373
941
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
134
107
13.32
138.72
2.4
2.2
%
11.0
12.5
0.46
63
53
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
235
396
6.57
135.88
2.3
1.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
208
318
7.16
131.88
6.6
5.3
iu/ml
380.2
830.0
0.50
25
44
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1450
8696
3.24
131.59
9.9
6.1
umol/l
10.3
11.6
6.88
1406
8242
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
125
98
13.51
130.75
2.3
2.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
208
333
6.83
126.18
5.0
3.8
%
52.3
58.0
4.10
208
333
(40760892) CBC W Ordered Manual Differential panel - Blood
822
3676
3.05
125.48
10.4
4.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
269
560
5.37
124.18
1.9
1.5
titre
90.8
146.1
0.76
13
23
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
124
105
12.50
123.68
3.4
2.5
e6/l
838.3
508.8
0.50
97
94
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
174
248
7.57
117.32
3.0
3.0
u/ml
935.2
2062.5
0.40
13
20
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
118
101
12.33
116.84
3.5
2.6
e9/l
0.2
0.2
0.04
97
93
(3021589) Normoblasts [#/volume] in Blood
1273
7448
2.85
114.02
20.6
9.3
e9/l
0.0
0.0
1.54
1109
6077
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
302
768
4.43
108.93
2.3
1.8
g/l
1.4
1.5
2.56
257
661
(3024980) IgG subclass 4 [Mass/volume] in Serum
164
240
7.34
107.86
1.7
1.7
g/l
1.3
0.9
1.37
113
183
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
164
241
7.31
107.45
1.4
1.2
u/l
53.3
50.9
0.04
147
207
(3018418) pH of Serum or Plasma
947
4917
2.71
104.68
7.0
3.9
ph
7.4
7.4
0.60
243
936
(3008757) Leukocyte morphology finding [Identifier] in Blood
139
174
8.49
104.52
8.6
3.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
711
3201
2.86
103.62
1.9
1.5
g/l
2.1
2.4
5.03
525
1939
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
184
326
6.10
100.54
1.4
1.4
—
18.5
—
0
7
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
183
323
6.12
100.38
1.4
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
102
91
11.74
98.20
2.5
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
102
91
11.74
98.20
2.5
1.8
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
248
589
4.65
97.18
2.0
2.6
g/l
3.1
3.1
0.12
200
470
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
554
2248
3.00
96.91
3.3
2.6
%
22.7
22.9
0.09
489
1916
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
256
628
4.51
96.28
2.0
2.5
g/l
3.6
3.8
1.71
199
460
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
256
629
4.50
96.08
2.0
2.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
256
629
4.50
96.08
2.0
2.5
g/l
7.1
7.4
1.18
202
482
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
234
537
4.79
95.62
2.1
2.7
g/l
0.5
1.3
2.96
207
473
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
245
586
4.61
95.10
2.0
2.6
g/l
9.9
10.3
0.63
206
505
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
112
121
9.73
94.36
3.7
2.2
e6/l
1480.5
685.2
0.37
48
47
(3037522) Nuclear Ab [Titer] in Serum
539
2186
2.98
94.06
1.5
1.3
titre
536.6
492.8
0.21
123
464
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
217
476
4.98
93.56
2.0
2.5
g/l
0.1
0.0
0.43
197
440
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1322
8361
2.62
93.52
10.9
6.7
mmol/l
1.2
1.2
0.51
1068
7066
(3023368) Bacteria identified in Blood by Culture
877
4602
2.57
91.92
6.9
4.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
219
493
4.85
91.49
1.9
2.4
g/l
38.0
37.4
0.57
192
430
(46235355) HIV 1 and 2 tests - Meaningful Use set
637
2870
2.76
90.83
1.7
1.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1233
7611
2.54
90.76
10.0
6.0
mmol/l
1.2
1.2
0.90
1151
6898
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
205
447
4.98
88.91
1.9
2.5
g/l
0.0
0.0
0.50
185
413
(3004789) Transferrin [Mass/volume] in Serum or Plasma
565
2420
2.84
88.49
3.2
2.5
g/l
2.3
2.3
0.37
530
2239
(3017354) Segmented neutrophils/100 leukocytes in Blood
120
156
8.11
87.29
6.6
3.0
%
43.7
54.6
3.04
79
107
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
163
294
5.93
87.24
1.4
1.4
u/ml
108.6
122.0
0.41
30
60
(3019420) Tryptase [Mass/volume] in Serum or Plasma
91
83
11.42
86.27
1.5
1.6
ug/l
9.0
8.7
0.03
78
71
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
201
444
4.91
85.77
2.0
2.5
g/l
0.0
0.0
0.00
185
412
(3003458) Phosphate [Moles/volume] in Serum or Plasma
536
2273
2.83
85.16
8.8
5.8
mmol/l
1.1
1.0
0.39
507
2105
(3026493) Urate [Moles/volume] in Serum or Plasma
834
4398
2.50
84.97
4.8
2.7
umol/l
2411.1
5681.7
2.21
762
3824
(3022948) Iron [Moles/volume] in Serum or Plasma
588
2631
2.73
84.08
3.3
2.5
umol/l
12.4
13.0
1.16
550
2428
(3024561) Albumin [Mass/volume] in Serum or Plasma
1169
7210
2.43
83.62
6.9
4.9
g/l
34.6
35.5
6.12
1089
6706
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
213
505
4.59
83.30
2.4
3.6
ratio
1.4
1.7
0.44
15
43
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
169
332
5.46
82.46
1.3
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
215
518
4.52
82.37
2.4
3.6
mg/l
46.0
61.7
0.60
166
421
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
215
520
4.50
81.96
2.4
3.6
mg/l
37.8
80.6
0.97
166
424
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1732
12949
3.10
81.15
14.3
7.3
u/l
81.5
78.4
2.14
1685
12176
(3012095) Magnesium [Moles/volume] in Serum or Plasma
590
2701
2.66
80.08
5.7
3.4
mmol/l
0.8
0.8
1.17
557
2534
(4062490)
111
147
7.92
79.43
1.4
1.4
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
110
146
7.90
78.56
1.4
1.4
g/l
6.7
6.8
0.06
70
103
(3028192) IgG subclass 2 [Mass/volume] in Serum
110
146
7.90
78.56
1.4
1.4
g/l
2.7
2.8
0.23
69
102
(3024139) IgG subclass 3 [Mass/volume] in Serum
110
146
7.90
78.56
1.4
1.4
g/l
0.4
0.4
0.29
69
102
(3036481) Cortisol [Moles/volume] in Serum or Plasma
403
1529
3.03
77.88
2.7
2.2
nmol/l
338.0
369.2
2.59
385
1399
(40758558) Short blood count panel - Blood
797
4247
2.43
77.86
14.1
6.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
191
438
4.70
77.73
1.9
2.1
mg/l
11.7
11.6
0.06
179
403
(3021879) Hepatitis B virus core Ab [Presence] in Serum
338
1173
3.25
75.98
1.4
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
449
1847
2.83
74.56
1.6
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
202
506
4.32
73.40
1.4
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1660
12424
2.72
71.99
7.0
4.0
mm/h
14.5
12.2
6.13
1580
11475
(40760888) Immunoglobulin light chains.free panel - Serum
172
388
4.75
71.31
2.4
3.8
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
43
11
39.90
70.27
8.7
6.3
—
—
—
0
0
(3026782) Osmolality of Urine
654
3317
2.42
69.96
3.4
2.7
mosm/kgh2o
541.5
548.2
0.34
582
2825
(3003327) Ova and parasites identified in Stool by Light microscopy
201
520
4.17
69.90
2.1
1.7
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
72
64
11.62
69.32
2.8
1.9
ug/l
51.1
151.9
0.35
66
53
(3048879) Bone marrow aspiration report
62
43
14.83
69.21
2.4
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
151
314
5.11
68.91
1.3
1.3
u/ml
249.9
249.9
0.00
101
192
(21494814) CD8 cells/100 lymphocytes in Specimen
67
54
12.79
68.59
2.5
1.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
56
34
16.90
66.97
1.2
1.4
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
42
13
32.96
65.13
1.1
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
40
11
37.06
64.09
1.1
1.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
186
485
4.12
63.87
1.9
1.5
g/l
1.1
1.2
1.53
175
455
(3002582) Erythrocytes [#/volume] in Urine
860
5050
2.21
63.73
4.3
3.3
e6/l
77.8
78.4
0.00
721
3915
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
182
469
4.16
63.50
1.9
1.5
g/l
0.2
0.2
1.80
168
441
(36304419) Bacteria [Presence] in Urine
792
4512
2.23
63.17
4.1
3.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
232
715
3.53
62.54
2.0
1.9
u/l
42.0
38.8
1.11
209
634
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
505
2392
2.47
61.77
1.6
1.6
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
58
44
13.53
61.50
2.2
2.7
e6/l
3025.9
226.7
0.75
37
27
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
135
284
5.02
60.70
2.8
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
660
3545
2.27
60.26
3.4
2.6
e6/l
5.7
5.4
0.09
595
3117
(3037756) Immunofixation for Serum or Plasma
152
357
4.52
59.78
1.5
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
162
403
4.28
59.16
2.6
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
795
4632
2.17
59.01
4.2
3.2
e6/l
0.3
0.4
2.28
667
3531
(4035726)
350
1420
2.76
58.57
1.5
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
158
391
4.29
58.08
2.8
1.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1373
9906
2.15
57.09
7.1
4.8
mmol/l
6.7
6.7
0.23
1315
9274
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
103
182
5.90
56.07
2.0
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
126
269
4.92
55.64
1.6
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
939
5927
2.07
55.50
4.9
3.7
e6/l
73.2
106.2
0.85
762
4213
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1093
7301
2.06
55.19
4.2
2.8
ug/l
195.3
126.0
2.45
1014
6724
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
539
2745
2.30
55.15
2.6
1.8
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
58
53
11.23
54.76
1.1
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
52
40
13.31
54.65
2.5
1.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1034
6822
2.03
53.44
11.4
9.5
inr
1.3
1.3
0.10
396
1966
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
408
1870
2.47
52.78
4.9
2.8
umol/l
7.3
8.2
0.34
355
1626
(3033658) Prothrombin time (PT) actual/Normal
734
4297
2.10
52.45
6.4
4.0
%
88.0
89.1
0.57
715
4189
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
740
4348
2.09
52.34
3.0
2.2
mg/l
3.2
2.9
1.69
640
3702
(3000012) Reticulocyte production index
67
84
8.21
50.06
2.1
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
91
161
5.87
49.44
1.0
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
864
5459
2.00
49.27
4.7
3.2
u/l
39.5
33.6
0.95
829
5179
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
51
48
10.87
47.17
5.3
2.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
498
2598
2.21
47.13
3.7
2.2
s
30.5
29.8
1.11
490
2517
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
63
79
8.19
47.05
2.8
2.5
u/ml
1414.1
1238.6
0.17
63
79
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
165
491
3.57
46.61
3.5
2.8
g/l
3.5
3.6
0.32
156
459
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
134
348
4.05
46.05
1.8
1.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
69
103
6.90
44.26
2.5
2.7
%
40.0
41.9
0.14
19
32
(1616796) Gas panel - Central venous blood
135
366
3.88
43.68
5.1
3.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1003
6858
1.90
43.61
3.0
2.2
nmol/l
76.9
76.9
0.02
929
6129
(40761536) Microorganisms panel - Urine sediment
326
1464
2.46
43.46
4.9
3.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
105
238
4.59
43.05
2.0
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
391
1912
2.29
42.90
2.2
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
371
1780
2.32
42.54
4.8
3.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
63
90
7.19
42.06
1.3
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
390
1928
2.26
41.58
2.3
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
860
5661
1.89
41.44
3.7
3.3
mmol/l
2.3
2.4
2.02
778
4939
(3042936) Bacteria identified in Isolate by Culture
456
2414
2.14
40.91
2.3
2.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
169
555
3.23
40.75
2.8
2.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
274
1174
2.54
40.23
2.1
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
99
227
4.53
40.00
2.8
2.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
304
1373
2.42
39.82
5.4
3.5
mmol/l
1.2
1.2
2.58
272
1184
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
83
165
5.20
39.73
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
86
177
5.03
39.57
2.4
2.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
325
1529
2.34
38.75
10.6
7.6
mmol/l
10.7
9.9
1.15
307
1459
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
45
8
57.45
38.42
1.4
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
111
287
4.03
38.33
1.8
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
798
5228
1.86
38.22
2.9
2.5
u/l
54.8
56.9
0.93
750
4835
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
153
492
3.28
38.16
2.2
1.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
129
378
3.57
37.21
5.7
4.4
mmol/l
2.4
2.5
0.09
90
251
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
609
3695
1.92
36.75
2.4
1.8
mg/l
1.2
1.2
0.04
478
2823
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
70
128
5.63
36.71
1.7
1.4
u/ml
5.7
0.6
1.02
29
64
(4212803)
29
16
18.37
36.06
1.2
1.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
169
605
2.95
35.04
1.3
1.2
u/ml
0.2
0.8
—
10
45
(3037467) Urinalysis macro (dipstick) panel - Urine
1457
11652
1.85
34.44
5.8
4.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
91
222
4.24
33.96
1.9
1.5
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
68
131
5.33
33.71
1.2
1.1
titre
60.0
147.5
—
9
24
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
68
132
5.29
33.42
2.0
1.6
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
144
484
3.12
33.31
5.8
4.1
mg/l
1.6
1.5
0.40
135
444
(3007853) Bacteria identified in Skin by Aerobe culture
374
1971
2.10
33.30
2.0
1.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
757
5056
1.79
32.78
3.0
2.2
u/l
166.7
234.7
2.07
711
4743
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
732
4841
1.79
32.78
3.6
3.0
ng/l
2004.8
1462.0
1.14
633
4122
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
143
486
3.09
32.45
1.4
1.3
—
—
—
0
0
(3010421) pH of Blood
137
457
3.14
32.09
5.8
4.1
ph
7.4
7.4
0.10
126
372
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
956
6887
1.72
31.27
2.3
2.0
pmol/l
94.4
94.4
0.02
552
3625
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1897
16844
2.56
31.02
30.2
14.2
mg/l
22.5
24.4
1.73
1683
13303
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
53
88
6.16
30.69
2.0
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
114
351
3.38
30.43
3.5
2.5
%
15.4
16.2
0.93
64
178
(3017732) Neutrophils [#/volume] in Blood
246
1138
2.32
30.12
3.3
2.9
e9/l
4.5
4.1
0.80
196
897
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
57
104
5.61
29.97
1.3
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
316
1623
2.12
29.88
2.5
2.3
g/l
0.2
0.2
1.32
286
1518
(3019309) Folate [Moles/volume] in Red Blood Cells
517
3151
1.85
29.79
2.1
1.7
nmol/l
1209.5
1171.0
0.41
416
2385
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
52
88
6.04
29.55
2.0
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
524
3222
1.84
29.27
4.5
3.7
ng/l
410.4
438.4
0.08
422
2521
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
84
216
4.01
29.22
1.8
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
33
33
10.15
29.20
2.8
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
87
231
3.89
28.95
3.3
2.7
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
113
357
3.29
28.95
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
113
357
3.29
28.95
1.5
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
91
253
3.72
28.36
1.8
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
70
161
4.47
28.18
1.1
1.2
u/l
100.9
55.0
0.48
49
112
(3031040) Bacteria [#/volume] in Urine by Automated count
1379
11143
1.72
28.13
5.8
4.4
e6/l
228.2
2020.9
1.99
33
152
(40768797) Stomach Pathology biopsy report
408
2350
1.92
27.80
1.3
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
886
6408
1.67
27.40
5.0
3.6
ng/l
95.3
53.7
0.33
641
4424
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
55
106
5.30
27.26
2.0
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
141
526
2.80
27.03
1.7
1.6
iu/ml
0.2
12.4
0.49
18
97
(3000494) Fungus identified in Specimen by Culture
355
1976
1.96
26.68
2.0
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
91
265
3.55
26.48
1.3
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1639
14004
1.83
26.43
36.5
17.2
%
14.3
13.7
29.60
1623
13678
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1351
10963
1.67
26.02
4.0
3.1
u/l
62.4
48.9
2.91
1265
10228
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
60
130
4.72
26.00
2.1
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
603
3980
1.73
25.94
1.9
1.5
nmol/l
20.4
20.6
0.11
549
3377
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
188
829
2.39
25.56
7.5
4.5
mmol/l
24.0
24.0
0.02
178
747
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
131
486
2.81
25.36
2.0
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
47
84
5.70
25.26
5.5
2.9
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
120
432
2.89
24.56
1.3
1.2
u/ml
35.0
32.5
—
5
19
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
88
264
3.44
24.47
1.1
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
62
145
4.38
24.45
1.2
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
114
400
2.96
24.44
1.4
1.2
u/ml
4.0
3.7
0.04
15
39
(3036489) Thrombin time
157
655
2.51
24.06
3.6
2.3
s
22.0
21.4
0.53
144
582
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
114
406
2.91
23.79
1.4
1.2
u/ml
5.3
7.5
0.26
23
65
(3021901) Oxygen saturation in Capillary blood
95
305
3.22
23.71
3.6
3.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
433
2662
1.79
23.56
3.6
3.0
e6/l
2.6
2.4
0.16
262
1470
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
452
2818
1.77
23.44
1.3
1.3
iu/ml
35.6
34.0
0.10
147
893
(3021601) Nitrite [Presence] in Urine by Test strip
1062
8242
1.59
23.37
5.9
4.9
estimate
0.0
0.0
0.50
318
1576
(3035350) Ketones [Presence] in Urine by Test strip
1060
8230
1.59
23.23
4.5
3.6
estimate
0.0
0.0
0.00
314
1546
(40768443) Skin Pathology biopsy report
163
706
2.42
23.02
1.5
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
58
135
4.39
23.02
1.1
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
87
270
3.32
22.94
1.1
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
42
74
5.77
22.92
4.5
3.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
712
5055
1.62
22.51
3.3
3.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
268
1433
2.00
22.37
12.2
9.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
127
495
2.67
22.35
5.4
3.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
644
4467
1.64
22.32
4.4
3.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1065
8332
1.57
22.18
4.5
3.6
estimate
0.0
0.0
0.16
292
1513
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
26
28
9.39
21.77
1.2
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1506
12850
1.64
21.08
4.5
4.0
pmol/l
14.8
14.8
0.29
1388
11655
(40768804) Tissue Pathology biopsy report
890
6737
1.56
21.04
2.4
2.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
94
322
3.01
21.03
1.3
1.2
u/ml
1.0
5.9
—
6
23
(40758292) HTLV I+II Ab panel - Serum
23
22
10.56
20.91
1.1
1.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
113
430
2.72
20.84
6.8
4.3
kpa
8.2
8.3
0.60
107
396
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
444
2850
1.71
20.44
3.5
2.8
e6/l
0.7
1.2
2.37
276
1648
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
25
28
9.03
20.33
1.6
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
538
3648
1.64
20.03
1.4
1.3
u/ml
1.2
1.5
0.28
144
958
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
117
463
2.62
19.98
1.6
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
113
440
2.66
19.93
4.4
3.4
mmol/l
24.8
24.8
0.00
101
382
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
60
160
3.83
19.89
3.6
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
101
372
2.80
19.83
2.9
2.3
g/l
122.6
130.1
1.70
75
280
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
64
181
3.62
19.49
3.5
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
735
5399
1.56
19.43
4.4
2.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
62
173
3.66
19.26
1.6
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
62
174
3.64
19.10
1.8
1.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
114
456
2.59
19.05
1.2
1.2
titre
121.0
85.3
—
10
36
(3048689) Calprotectin [Mass/mass] in Stool
329
1977
1.79
18.98
2.5
2.4
ug/g
168.6
128.6
0.70
264
1572
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
466
3088
1.66
18.84
3.2
3.0
mmol/l
2.5
2.4
0.30
401
2722
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
47
109
4.39
18.77
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
47
109
4.39
18.77
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
47
109
4.39
18.77
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
47
110
4.35
18.56
1.2
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
47
110
4.35
18.56
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
47
110
4.35
18.56
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
47
110
4.35
18.56
1.2
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
88
312
2.90
18.54
1.3
1.2
—
—
—
0
0
(3012544) pH of Venous blood
284
1643
1.84
18.54
6.3
4.1
ph
7.4
7.4
—
5
7
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
89
318
2.88
18.49
1.3
1.2
u/ml
38.2
46.7
0.19
12
29
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
47
111
4.31
18.35
1.3
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
32
54
6.00
18.25
1.6
1.5
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
20
19
10.62
18.23
1.7
2.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
276
1594
1.84
18.09
6.5
4.0
mmol/l
1.7
1.9
0.28
226
1276
(3014111) Lactate [Moles/volume] in Serum or Plasma
261
1484
1.87
17.97
9.5
7.3
mmol/l
1.5
1.4
0.35
252
1430
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
34
62
5.56
17.92
5.2
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
414
2708
1.66
17.45
1.3
1.2
u/ml
11.9
13.0
0.13
125
1048
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
33
60
5.57
17.45
5.4
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
33
60
5.57
17.45
5.4
1.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1881
17310
1.98
17.38
30.5
16.4
mmol/l
139.3
139.6
6.83
1853
16865
(3022145) Colonoscopy Study observation
303
1831
1.77
17.04
1.3
1.3
—
—
—
0
0
(3015736) pH of Urine
832
6411
1.50
16.99
3.8
3.4
—
5.8
—
0
6
(3003434) Protein [Mass/volume] in Pleural fluid
69
224
3.15
16.96
1.7
1.5
g/l
34.9
32.5
0.71
60
196
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
126
558
2.34
16.91
8.1
3.1
u/ml
0.3
0.4
0.35
79
317
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
40
89
4.56
16.83
1.1
1.2
u/l
128.1
79.9
1.37
34
80
(3023103) Potassium [Moles/volume] in Serum or Plasma
1882
17352
1.96
16.83
31.6
16.6
mmol/l
4.0
4.0
1.34
1848
16877
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
201
1072
1.97
16.75
6.7
4.1
mmol/l
2.2
1.7
1.18
149
799
(3021447) Carbon dioxide [Partial pressure] in Venous blood
272
1601
1.81
16.70
6.6
4.0
kpa
5.9
5.9
0.67
258
1556
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
53
147
3.67
16.64
1.0
1.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
143
676
2.20
16.44
2.8
1.8
ug/l
1.9
1.9
0.03
129
600
(3009343) pH of Capillary blood
206
1115
1.94
16.44
6.7
4.1
ph
7.4
7.4
1.01
51
132
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
996
8010
1.47
16.14
6.2
4.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
37
80
4.69
16.13
4.9
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
37
80
4.69
16.13
4.9
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
37
80
4.69
16.13
4.9
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
37
80
4.69
16.13
4.9
1.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
173
892
2.03
15.85
11.3
10.1
mmol/l
24.1
24.3
0.40
165
829
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
206
1131
1.91
15.74
6.7
4.1
kpa
5.1
5.1
0.02
192
1058
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
38
86
4.48
15.67
1.1
1.2
u/l
47.6
16.2
1.32
32
76
(3035637) Corticotropin [Mass/volume] in Plasma
64
209
3.13
15.59
1.7
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
107
462
2.39
15.22
1.4
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
609
4480
1.51
15.17
5.0
3.9
estimate
0.0
0.0
1.28
295
1513
(44790047)
61
198
3.14
15.02
1.8
1.5
—
—
—
0
0
(44790048)
61
198
3.14
15.02
1.8
1.5
—
—
—
0
0
(44790049)
61
198
3.14
15.02
1.8
1.5
—
—
—
0
0
(44806118)
61
198
3.14
15.02
1.8
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
55
170
3.30
14.68
4.1
4.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
27
48
5.69
14.62
1.3
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
260
1568
1.75
14.62
2.8
2.4
u/l
32.8
71.7
0.69
232
1329
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
40
100
4.06
14.54
1.6
1.5
u/l
7.8
7.6
0.02
23
49
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
26
45
5.84
14.47
1.3
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
35
80
4.43
14.28
1.6
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
238
1412
1.77
14.14
3.8
3.0
ng/l
266.5
221.5
0.69
214
1291
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
29
57
5.15
14.11
1.4
1.3
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
42
113
3.77
13.81
2.0
1.4
u/ml
18.2
19.5
—
6
27
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
31
67
4.68
13.54
2.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
31
67
4.68
13.54
2.0
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
36
88
4.15
13.49
1.9
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
36
88
4.15
13.49
1.9
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
1359
11804
1.44
13.43
4.9
3.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
26
49
5.36
13.25
1.8
1.7
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
26
49
5.36
13.25
1.4
1.3
—
—
—
0
0
(3000492) Spirometry study
256
1586
1.70
13.01
1.8
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
63
227
2.83
12.96
1.3
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
504
3666
1.50
12.92
1.8
1.7
pmol/l
52068561.2
31334858.0
0.22
411
3035
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
47
143
3.34
12.89
4.1
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
47
143
3.34
12.89
4.1
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
47
143
3.34
12.89
4.1
1.5
—
—
—
0
0
(44813793)
39
105
3.77
12.83
1.2
1.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
55
185
3.03
12.79
1.5
1.4
e6/l
181894.8
104624.1
0.25
36
107
(3027801) Oxygen [Partial pressure] in Arterial blood
299
1946
1.63
12.55
9.3
7.7
kpa
11.7
12.1
0.68
281
1865
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
299
1946
1.63
12.55
9.4
7.7
kpa
5.1
5.1
0.19
281
1862
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1691
15408
1.54
12.49
5.5
4.7
mu/l
1.9
2.1
0.63
1570
14063
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1724
15781
1.56
12.41
26.2
13.1
ml/min/173m2
80.1
80.8
0.62
1533
12975
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
178
1006
1.84
12.39
2.0
1.6
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
29
65
4.51
12.14
1.1
1.6
iu/ml
—
1903858.3
—
0
6
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
45
139
3.29
12.06
1.5
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
87
381
2.34
12.04
2.7
3.0
umol/l
34.5
34.5
0.00
78
324
(3009508) Creatinine [Moles/volume] in Urine
685
5342
1.42
12.03
3.6
3.2
mmol/l
7.2
7.6
1.34
563
4495
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
121
606
2.06
12.01
3.1
2.3
ug/l
669.0
492.1
0.24
114
569
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
68
266
2.61
11.97
1.3
1.2
u/ml
4.6
3.7
0.12
19
90
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
191
1116
1.78
11.92
2.4
2.4
au/ml
29.8
22.6
—
8
63
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
53
182
2.96
11.91
1.2
1.2
nmol/l
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
295
1943
1.60
11.75
9.5
7.7
mmol/l
1.0
1.1
0.10
230
1510
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
66
257
2.62
11.73
1.3
1.2
u/ml
4.8
5.7
0.16
29
110
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
214
1298
1.72
11.72
5.4
4.0
ng/l
96.7
90.4
0.45
189
1134
(3024354) Oxygen [Partial pressure] in Venous blood
216
1316
1.72
11.64
5.9
3.3
kpa
4.6
4.5
0.04
201
1278
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
30
72
4.21
11.54
1.4
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
172
984
1.82
11.51
2.8
3.5
pmol/l
4.6
4.5
0.12
145
876
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
72
296
2.48
11.45
3.2
2.9
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1900
17893
1.78
11.33
19.9
10.2
u/l
26.6
26.2
0.34
1869
17267
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
35
96
3.69
11.24
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
52
183
2.89
11.20
1.2
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
57
211
2.75
11.19
1.6
1.4
e6/l
3146.6
1952.0
0.74
45
148
(3000570) Elastase.pancreatic [Mass/mass] in Stool
101
486
2.13
11.15
1.5
1.5
ug/g
280.5
281.5
0.02
64
292
(3004616) Nuclear Ab [Presence] in Serum
54
195
2.82
11.11
1.5
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
639
4978
1.41
11.10
3.6
3.3
mg/l
907.8
313.5
1.44
443
3204
(3024471) HLA-A [Type]
25
54
4.67
10.95
1.0
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
787
6367
1.38
10.88
4.8
3.8
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
56
210
2.71
10.74
1.2
1.2
nmol/l
0.2
0.4
—
7
16
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
174
1024
1.76
10.59
1.5
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
36
105
3.47
10.58
8.1
3.7
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1893
17870
1.72
10.36
32.2
16.5
umol/l
82.9
77.9
4.70
1893
17864
(3028433) Virus identified in Specimen by Culture
24
53
4.57
10.25
1.5
1.3
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
15
21
7.19
10.14
4.9
3.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
156
903
1.79
10.05
1.5
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
205
1286
1.66
9.88
1.2
1.2
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
20
39
5.17
9.84
1.3
1.3
ug/l
82.1
32.2
—
10
20
(3020682) Albumin/Creatinine [Ratio] in Urine
658
5237
1.38
9.81
4.6
4.1
mg/mmol
13.9
8.9
1.52
429
3340
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
54
209
2.63
9.76
1.2
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
51
194
2.67
9.55
1.2
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
154
902
1.76
9.54
11.7
10.9
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
57
230
2.52
9.48
1.1
1.1
g/l
1.7
1.5
1.87
52
206
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
31
89
3.52
9.35
1.1
1.1
u/l
112.8
85.2
0.84
26
68
(3024932) HLA-DR beta [Type]
23
53
4.38
9.34
1.1
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
536
4155
1.39
9.30
4.3
2.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
259
1745
1.55
9.28
10.2
8.2
%
95.1
95.5
0.50
244
1686
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
31
90
3.48
9.20
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
31
90
3.48
9.20
1.0
1.0
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
31
90
3.48
9.20
1.1
1.1
u/l
49.5
24.1
1.32
24
64
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
16
27
5.96
9.12
2.8
3.1
u/l
53.6
41.4
—
5
10
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
36
117
3.11
8.95
1.3
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
303
2134
1.49
8.81
1.4
1.3
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
31
93
3.37
8.77
2.2
1.4
u/l
6.1
8.2
0.53
26
76
(40761511) CBC panel - Blood by Automated count
1857
17554
1.58
8.76
24.1
13.4
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
46
174
2.68
8.73
1.6
1.5
mmol/l
6.0
6.6
0.94
41
160
(3011985) Renin [Units/volume] in Plasma
50
198
2.56
8.67
1.6
1.3
mu/l
43.4
42.4
0.02
43
174
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
63
279
2.30
8.58
1.2
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
32
100
3.23
8.50
1.6
1.7
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
47
183
2.60
8.44
1.4
1.4
pmol/l
405.9
271.0
1.08
36
135
(3014148) Varicella zoster virus Ab [Titer] in Serum
47
183
2.60
8.44
1.3
1.2
—
—
—
0
0
(4010399)
187
1199
1.62
8.27
1.7
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
49
197
2.52
8.25
2.0
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
49
197
2.52
8.25
2.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
49
197
2.52
8.25
2.0
1.4
—
—
—
0
0
(3013512) EKG study
608
4886
1.35
8.24
4.6
3.8
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
13
9
14.52
8.20
1.2
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
49
198
2.51
8.17
2.0
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
179
1139
1.63
8.16
4.6
5.0
—
—
—
0
0
(3035880) pH of Pleural fluid
31
98
3.20
8.09
1.5
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1187
10497
1.31
8.03
3.3
3.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
33
109
3.06
8.02
1.3
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
49
200
2.49
8.01
2.0
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
21
51
4.15
8.00
1.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
44
171
2.61
7.95
7.6
3.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
18
39
4.65
7.88
1.4
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
32
105
3.08
7.86
1.7
2.0
min
548.8
494.0
1.89
23
71
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
71
343
2.11
7.85
1.9
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
64
298
2.18
7.76
1.5
1.3
mmol/l
63.0
62.1
0.07
56
240
(3014576) Chloride [Moles/volume] in Serum or Plasma
298
2143
1.46
7.75
11.5
7.1
mmol/l
104.2
104.3
0.12
292
2089
(40768446) Kidney Pathology biopsy report
22
57
3.89
7.70
1.5
1.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
30
96
3.16
7.69
1.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
44
174
2.56
7.68
1.8
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
45
180
2.53
7.68
1.5
2.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
15
29
5.20
7.45
1.5
1.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
12
9
13.40
7.38
2.9
3.3
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
37
137
2.73
7.36
1.7
2.2
ml
666.0
629.1
0.20
26
86
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
45
184
2.48
7.35
1.2
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1650
15372
1.37
7.27
6.6
5.8
mmol/mol
40.2
39.9
0.73
1518
14201
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
116
679
1.75
7.25
3.5
1.8
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
12
19
6.35
7.24
2.5
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
26
80
3.28
7.11
1.3
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
49
212
2.34
7.09
1.7
1.6
%
52.1
60.8
0.69
33
134
(3024522) Salmonella sp identified in Specimen by Organism specific culture
47
200
2.38
7.06
2.1
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
84
449
1.91
7.04
1.6
1.4
u/l
9.8
9.3
0.10
64
359
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
23
66
3.51
6.99
2.5
2.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
70
352
2.02
6.99
1.9
1.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
231
1613
1.49
6.97
10.6
8.6
g/l
115.5
121.4
3.94
220
1555
(40757373) Influenza virus identified in Isolate
17
39
4.39
6.96
1.8
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1649
15406
1.35
6.78
31.8
15.2
%
39.1
39.7
2.28
1146
10969
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
21
58
3.65
6.75
2.1
2.3
ug/l
50.6
54.5
0.14
21
58
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
16
36
4.47
6.71
1.1
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
39
156
2.53
6.69
3.3
2.5
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
53
244
2.20
6.66
1.1
1.1
%
117.1
116.3
0.06
48
227
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
27
90
3.03
6.50
3.1
7.1
u/ml
—
58.9
—
0
26
(3024928) Oxygen saturation in Venous blood
70
363
1.96
6.44
4.2
2.8
—
—
—
0
0
(4268621)
42
178
2.39
6.39
2.6
2.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
59
290
2.06
6.30
1.2
1.1
u/ml
0.4
2.7
2.61
29
131
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
9
5
18.07
6.26
2.7
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
30
109
2.78
6.22
2.2
1.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
36
144
2.53
6.20
1.1
1.1
—
—
—
0
0
(4306422)
52
246
2.14
6.13
1.2
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
104
620
1.71
6.13
2.1
1.7
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
43
188
2.31
6.12
9.2
6.9
mmol/l
7.1
7.4
0.24
34
157
(3037121) Protein [Mass/volume] in Urine
105
632
1.70
5.99
2.8
3.5
g/l
0.3
0.3
0.25
59
269
(3001686) Cold agglutinin [Titer] in Serum or Plasma
14
31
4.54
5.98
1.6
1.4
—
185.3
—
0
6
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
32
123
2.63
5.98
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
47
216
2.20
5.96
1.6
1.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
11
20
5.52
5.81
2.6
2.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
66
353
1.90
5.59
2.9
1.6
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
9
7
12.91
5.58
2.7
1.0
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
42
190
2.24
5.55
1.5
1.3
mosm/kgh2o
272.4
279.4
1.33
36
138
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
161
1095
1.51
5.54
1.3
1.2
iu/ml
65.9
148.4
3.02
51
429
(3052592) Norovirus Ag [Presence] in Stool
12
25
4.82
5.49
1.4
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
32
129
2.50
5.46
1.3
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
20
62
3.25
5.45
1.2
1.1
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
5
16.06
5.41
1.0
1.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
8
5
16.06
5.41
1.0
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
16
43
3.74
5.37
1.4
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
11
22
5.02
5.26
1.6
1.6
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
26
4.64
5.26
4.1
5.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
12
26
4.64
5.26
1.2
1.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
111
703
1.61
5.23
1.5
1.4
iu/l
24.4
27.2
0.41
92
588
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
32
132
2.45
5.21
1.2
1.2
mg/l
37.3
40.5
0.17
25
108
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
157
1078
1.49
5.17
13.2
9.5
%
0.6
0.7
0.57
152
1071
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
230
1703
1.39
5.06
2.9
4.2
ug/l
41.4
16.9
0.42
184
1391
(3047189) Immunofixation for 24 hour Urine
23
82
2.83
4.98
1.4
1.6
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
121
794
1.56
4.93
1.1
1.1
titre
—
165.1
—
0
13
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
11
24
4.60
4.78
2.5
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
11
24
4.60
4.78
2.5
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
11
24
4.60
4.78
2.5
1.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
35
158
2.24
4.70
1.6
1.4
%
28.3
30.1
0.09
20
97
(3011288) Drugs identified in Urine by Screen method
67
382
1.78
4.69
4.1
2.6
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
25
97
2.60
4.64
1.1
1.1
ratio
1.1
1.0
0.47
11
40
(3010726) Horse dander IgE Ab [Units/volume] in Serum
47
240
1.98
4.61
1.2
1.1
u/ml
4.4
2.7
—
9
64
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
16
48
3.35
4.60
1.2
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
49
254
1.95
4.60
1.2
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
13
34
3.84
4.53
1.2
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
20
70
2.88
4.49
2.0
2.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
14
39
3.61
4.48
2.1
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
259
1994
1.34
4.47
2.2
1.8
%
1.6
1.5
1.28
230
1741
(3021788) Differential panel - Synovial fluid
56
307
1.85
4.46
1.8
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1929
18729
1.46
4.33
44.0
20.8
e9/l
254.5
249.6
1.53
1895
18261
(3003694) ABO and Rh group [Type] in Blood
551
4689
1.24
4.31
1.6
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
20
72
2.80
4.28
1.1
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
18
61
2.97
4.28
2.1
1.2
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
8
9
8.92
4.28
1.3
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
37
178
2.10
4.27
2.7
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
524
4439
1.24
4.27
1.8
1.6
mmol/l
1.6
1.4
4.19
427
3721
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
66
386
1.73
4.26
2.9
1.6
e6/l
669.4
748.0
0.06
58
315
(3024731) MCV [Entitic volume]
1929
18737
1.45
4.23
43.8
20.8
fl
91.9
91.0
9.92
1910
18462
(3022313) Gas panel - Capillary blood
122
831
1.50
4.22
7.9
4.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
46
241
1.93
4.22
1.3
1.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
1929
18739
1.45
4.21
43.7
20.7
pg
30.3
30.3
0.25
1909
18461
(3026361) Erythrocytes [#/volume] in Blood
1929
18740
1.45
4.20
43.9
20.8
e12/l
4.4
4.5
17.86
1888
18213
(3000963) Hemoglobin [Mass/volume] in Blood
1929
18745
1.44
4.14
44.3
21.0
g/l
130.9
135.2
25.95
1909
18465
(3010813) Leukocytes [#/volume] in Blood
1929
18746
1.44
4.13
44.0
20.9
e9/l
10.6
6.8
28.90
1887
18216
(3028707) Methadone [Presence] in Urine by Screen method
48
258
1.88
4.09
2.4
2.3
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
20
74
2.72
4.09
1.8
1.4
umol/l
24.8
26.3
0.07
20
68
(1001926) Buprenorphine [Presence] in Urine by Screen method
72
437
1.67
4.08
2.4
1.9
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
72
438
1.67
4.05
1.3
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1705
16288
1.27
4.04
5.1
4.5
mmol/l
6.1
6.0
2.00
1559
14796
(3049717) Cytology report of Urine Cyto stain
103
684
1.53
4.03
2.3
2.6
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
65
386
1.71
4.00
2.8
1.6
e6/l
8.3
31.1
0.81
55
303
(3011648) Oxygen content in Venous blood
30
137
2.21
3.96
5.4
1.9
%
10.0
11.1
0.76
30
137
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
70
426
1.67
3.94
1.2
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
10
24
4.18
3.89
2.0
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
86
554
1.58
3.86
2.5
2.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
16
54
2.98
3.85
7.3
4.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
19
71
2.69
3.82
1.1
1.1
ng/l
84.7
288.1
—
7
19
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
46
250
1.86
3.81
1.2
1.1
—
—
—
0
0
(4198724)
17
60
2.85
3.79
2.0
1.6
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
37
187
2.00
3.79
1.9
2.1
umol/l
15.9
8.5
0.43
19
136
(3027008) Opiates [Presence] in Urine
86
559
1.56
3.72
2.5
2.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
33
161
2.07
3.71
1.5
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
78
496
1.60
3.71
1.3
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
17
61
2.80
3.69
1.1
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
46
253
1.84
3.68
1.1
1.1
u/ml
1.6
5.6
2.64
24
132
(3028300) Cannabinoids [Presence] in Urine
86
561
1.56
3.67
2.6
1.9
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
13
40
3.26
3.62
1.2
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
84
547
1.56
3.62
2.6
1.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
123
869
1.44
3.58
2.7
2.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
99
1431
0.68
3.57
1.3
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
66
407
1.64
3.56
1.8
1.7
e6/l
12176.1
14843.5
0.26
45
305
(3019225) pH of Specimen
217
1686
1.32
3.54
6.9
4.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
82
534
1.56
3.54
2.0
2.2
u/l
9028.5
3504.3
0.41
26
214
(4027681)
24
105
2.30
3.52
1.4
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
26
118
2.22
3.51
1.2
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
164
1225
1.37
3.47
2.7
2.2
nmol/l
11.9
12.6
0.49
137
1072
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
21
87
2.43
3.47
2.0
1.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
14
363
0.38
3.45
1.8
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
64
395
1.64
3.45
2.5
1.4
mmol/l
3.7
3.8
0.26
57
370
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
16
391
0.40
3.44
1.8
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
14
362
0.38
3.43
1.8
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
77
498
1.57
3.43
1.4
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
14
361
0.38
3.41
1.8
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
14
361
0.38
3.41
1.8
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
21
88
2.40
3.39
1.2
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
19
430
0.44
3.39
1.6
1.4
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
18
70
2.59
3.38
1.7
3.1
umol/l
86.4
118.4
—
8
42
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
104
720
1.47
3.38
8.7
4.5
mmol/l
24.8
24.8
0.10
98
682
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
7
10
7.02
3.36
2.1
6.8
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
10
27
3.72
3.35
1.8
3.7
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
37
196
1.90
3.35
1.2
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
8
14
5.73
3.34
1.0
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
79
519
1.54
3.30
2.7
2.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
77
504
1.55
3.27
1.4
1.2
—
—
—
0
0
(4034850)
28
544
0.51
3.27
24.2
9.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
343
2852
1.24
3.26
1.6
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
101
1426
0.69
3.23
2.0
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
105
736
1.45
3.22
1.9
1.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
267
2160
1.27
3.21
23.0
26.5
inr
1.2
1.4
0.60
33
308
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
67
427
1.59
3.20
2.7
2.4
ug/min
170.3
99.5
0.42
41
257
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
71
459
1.57
3.19
1.4
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
43
245
1.77
3.12
1.1
1.1
u/ml
0.3
1.3
1.48
21
115
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
99
2.24
3.06
1.2
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
15
56
2.69
3.06
1.3
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
33
174
1.91
3.05
1.1
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
159
2066
0.75
3.05
9.1
7.1
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
14
51
2.76
2.98
1.9
1.5
%
22.5
28.2
0.37
14
46
(3019832) Treponema pallidum Ab [Presence] in Serum
184
1433
1.31
2.98
1.5
1.6
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
5
5
10.02
2.98
1.0
1.0
—
—
—
0
0
(3019977) pH of Arterial blood
21
94
2.25
2.96
3.3
3.1
ph
7.4
7.4
—
10
30
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
27
134
2.03
2.96
1.3
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
43
250
1.74
2.93
5.2
5.3
umol/l
411.3
356.5
1.44
35
221
(3002523) Influenza virus A Ag [Presence] in Specimen
45
266
1.71
2.90
1.4
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
14
52
2.70
2.89
1.7
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
448
3874
1.20
2.88
4.0
3.6
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
9
23
3.93
2.77
7.9
5.7
mmol/l
4.5
6.9
—
9
23
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
21
97
2.18
2.77
1.0
1.1
iu/ml
3.0
8.4
—
5
22
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
67
445
1.52
2.72
1.2
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
19
85
2.25
2.70
1.8
1.4
%
9.8
4.1
—
6
16
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
84
586
1.45
2.69
1.6
1.6
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
10
32
3.14
2.64
1.2
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
10
32
3.14
2.64
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
10
32
3.14
2.64
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
10
32
3.14
2.64
1.2
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
30
163
1.85
2.58
1.4
1.3
e6/l
36885.8
124311.9
0.74
17
113
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
303
0.43
2.57
1.8
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
27
143
1.90
2.51
1.5
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
45
278
1.63
2.50
1.7
1.4
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
9
26
3.47
2.48
1.7
3.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
109
2.03
2.46
1.4
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
43
264
1.64
2.45
1.4
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
13
51
2.56
2.44
1.2
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
13
296
0.44
2.44
1.8
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
13
294
0.44
2.40
1.8
1.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
6
12
5.01
2.40
2.3
8.2
—
—
—
0
0
(3001729) Color of Synovial fluid
6
12
5.01
2.40
1.3
1.2
—
—
—
0
0
(3025315) Body weight
6
12
5.01
2.40
4.0
3.9
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
34
197
1.74
2.39
1.2
1.0
u/ml
14.4
3.3
0.65
12
76
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
107
801
1.35
2.32
4.6
2.6
%
1.5
1.2
1.10
107
796
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
11
41
2.69
2.28
3.9
2.0
mmol/l
6.8
7.5
—
6
22
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
11
41
2.69
2.28
2.4
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
6
13
4.63
2.27
1.0
1.5
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
75
531
1.43
2.26
6.1
6.8
mmol/l
1.3
1.3
0.02
60
465
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
21
106
1.99
2.25
1.2
1.1
u/l
1.0
1.1
—
10
54
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
7
18
3.90
2.25
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
139
1087
1.30
2.24
1.2
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
180
1455
1.26
2.23
2.4
2.4
ug/l
11.7
6.8
0.54
153
1293
(3024869) Neuronal Ab [Presence] in Serum
9
29
3.11
2.22
1.0
1.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
5
9
5.57
2.21
1.0
1.6
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
133
1038
1.30
2.18
4.8
3.1
g/l
123.5
128.6
1.51
128
1011
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
24
3.34
2.18
1.4
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
31
181
1.72
2.15
1.2
1.1
u/ml
1.3
5.2
—
8
74
(3044009) aPTT.lupus sensitive (LA screen)
7
19
3.69
2.15
1.1
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
9
30
3.01
2.14
1.2
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
16
74
2.17
2.14
1.2
2.4
%
172.3
144.7
0.45
16
69
(3023410) Appearance of Cerebral spinal fluid
30
175
1.72
2.10
4.6
1.8
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
78
565
1.40
2.09
1.7
1.6
mu/l
287.7
307.7
0.23
68
516
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
9
31
2.91
2.07
2.7
2.2
umol/l
16.1
17.3
—
9
31
(3036525) Urea [Moles/time] in 24 hour Urine
5
10
5.01
2.07
2.6
4.9
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
10
5.01
2.07
2.4
3.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
136
1075
1.28
2.04
7.8
7.3
mmol/l
24.7
24.4
0.38
125
1004
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
8
26
3.08
2.01
1.4
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
10
38
2.64
2.01
2.5
1.9
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
9
32
2.82
2.00
1.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
71
971
0.72
1.98
1.6
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
22
119
1.86
1.97
1.8
2.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
17
84
2.03
1.95
2.2
1.7
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
16
3.76
1.93
1.7
2.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
16
3.76
1.93
1.3
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
63
447
1.42
1.92
2.3
1.8
nmol/l
35.9
39.6
0.60
57
431
(3043410) Blood group antigens tested for on Red Blood Cells
13
58
2.25
1.91
2.4
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
17
85
2.01
1.90
4.0
2.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
14
65
2.16
1.88
1.1
1.1
miu/ml
2143.5
1611.9
0.91
14
65
(1761868) Lipid panel - Serum or Plasma
634
5815
1.13
1.81
3.3
2.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
43
287
1.51
1.80
1.5
1.4
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
9
35
2.58
1.80
1.3
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
35
2.58
1.80
1.4
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
45
304
1.49
1.78
1.9
1.3
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
17
88
1.94
1.75
1.2
1.4
nmol/l
1.5
1.2
0.31
12
69
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
18
3.34
1.74
1.2
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
18
3.34
1.74
1.5
1.2
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
12
54
2.23
1.74
1.4
1.3
%
67.4
89.4
—
7
27
(3022621) pH of Urine by Test strip
135
1092
1.25
1.72
3.2
2.9
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
58
415
1.41
1.72
1.9
1.9
iu/l
6.0
4.9
0.30
25
144
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
66
484
1.38
1.70
1.2
1.3
miu/ml
190.1
227.5
0.39
23
224
(3018851) Theophylline [Moles/volume] in Serum or Plasma
6
19
3.16
1.66
1.0
1.4
umol/l
47.5
51.1
—
6
19
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
14
3.58
1.61
1.2
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
12
56
2.15
1.61
1.3
1.1
%
73.3
92.7
—
7
28
(43055514) Macroprolactin [Presence] in Serum or Plasma
8
32
2.51
1.59
1.9
1.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
80
612
1.32
1.59
2.7
3.5
u/ml
21.1
6561.6
0.83
72
523
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
17
92
1.85
1.56
12.5
11.4
mmol/l
0.6
0.6
0.52
17
86
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
21
2.86
1.50
1.0
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
21
2.86
1.50
1.5
1.5
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
16
87
1.85
1.46
1.8
1.7
u/field
3.7
4.9
0.20
11
64
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
11
52
2.12
1.44
1.9
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
14
73
1.92
1.44
1.2
1.2
—
—
—
0
0
(4211845)
14
73
1.92
1.44
1.4
2.9
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
34
494
0.68
1.41
1.4
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
16
88
1.82
1.41
1.1
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1694
16547
1.13
1.39
4.8
4.4
mmol/l
4.5
4.6
8.20
1580
15281
(3027456) Digoxin [Moles/volume] in Serum or Plasma
49
356
1.39
1.38
3.1
3.1
nmol/l
0.7
0.8
0.73
37
277
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
6
23
2.61
1.36
2.3
1.3
ng/l
95.5
99.8
—
6
23
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
17
2.95
1.36
5.6
5.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
22
135
1.64
1.36
2.5
2.2
u/field
1.5
2.2
—
8
54
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1723
16858
1.13
1.34
5.2
4.9
mmol/l
2.6
2.7
6.71
1600
15469
(1002224) Polysomnography panel
82
647
1.28
1.34
1.1
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
13
68
1.92
1.33
1.4
3.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
149
0.47
1.31
1.3
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
71
552
1.30
1.30
1.2
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
18
2.78
1.28
3.4
1.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
160
1367
1.18
1.25
3.3
2.6
ml/min/173m2
57.7
66.3
2.01
84
541
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1626
15873
1.11
1.25
4.4
3.9
mmol/l
1.4
1.3
7.67
1503
14484
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
6
25
2.40
1.24
1.0
1.2
umol/24h
2.2
1.8
—
6
25
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
25
2.40
1.24
1.3
1.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
8
36
2.23
1.24
3.1
1.9
mmol/l
1.2
1.2
—
8
36
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
8
36
2.23
1.24
1.0
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
8
36
2.23
1.24
3.4
3.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
17
100
1.71
1.23
1.6
1.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
11
56
1.97
1.22
2.2
2.3
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
5
19
2.64
1.21
1.2
1.1
u/ml
0.0
2.2
—
5
12
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
5
19
2.64
1.21
1.0
1.3
u/l
22.5
26.9
—
5
12
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
17
101
1.69
1.19
2.8
2.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
71
1.84
1.19
1.3
1.2
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
6
26
2.31
1.18
1.2
1.1
u/ml
0.0
0.5
—
6
20
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
8
38
2.11
1.18
1.0
1.5
%
108.9
100.0
—
8
33
(3006270) Folate [Moles/volume] in Blood
21
133
1.58
1.17
1.0
1.2
nmol/l
349.4
380.4
0.31
16
118
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
11
57
1.93
1.17
1.5
1.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
46
342
1.35
1.16
2.2
3.6
u/ml
22.3
1129.0
0.88
40
325
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
18
110
1.64
1.15
1.1
1.1
—
—
—
0
0
(44806071)
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
5
20
2.50
1.15
1.2
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
39
283
1.39
1.14
1.3
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
50
378
1.33
1.14
2.4
2.1
—
—
—
0
0
(3039000) Anion gap in Blood
50
378
1.33
1.14
6.8
7.8
mmol/l
11.6
11.3
0.23
43
342
(3018572) Chloride [Moles/volume] in Blood
50
379
1.33
1.12
6.8
7.8
mmol/l
106.0
105.3
0.56
43
343
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
32
225
1.43
1.12
1.5
1.4
nmol/l
0.2
0.3
1.64
26
179
(4133840)
8
40
2.00
1.12
1.4
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
199
1748
1.15
1.12
2.0
2.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
51
1.97
1.11
1.5
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
13
73
1.79
1.11
1.1
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
181
1582
1.16
1.09
2.0
1.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
28
193
1.46
1.09
1.6
1.8
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
41
1.95
1.08
7.5
6.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
16
97
1.65
1.06
3.4
2.5
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
52
1.93
1.06
1.5
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
33
2.12
1.05
1.4
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
33
2.12
1.05
1.4
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
20
129
1.56
1.05
1.4
1.4
mmol/l
11.9
12.0
—
5
36
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
18
114
1.58
1.02
1.1
1.1
nmol/l
0.4
3.9
—
5
21
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
84
691
1.22
1.01
5.8
5.6
%
1.9
1.6
1.04
76
648
(3035933) Granulocytes/100 leukocytes in Blood
10
53
1.89
1.01
1.3
2.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
9
48
1.88
1.00
1.3
2.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
99
830
1.20
0.99
4.1
3.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
29
0.00
0.97
0.0
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
9
50
1.80
0.96
1.2
2.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
83
687
1.22
0.96
6.0
5.6
%
0.9
0.9
0.08
75
645
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
37
1.89
0.94
8.3
6.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
32
234
1.37
0.93
1.5
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
100
847
1.19
0.92
1.4
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
273
2484
1.11
0.91
1.5
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
13
78
1.67
0.91
16.8
13.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
47
367
1.29
0.90
6.0
3.7
mg/l
26.2
27.1
0.07
30
237
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
49
385
1.28
0.90
1.7
1.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
124
1428
0.86
0.89
4.9
3.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
14
87
1.61
0.87
3.8
2.7
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
30
2.00
0.87
1.0
3.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
8
44
1.82
0.86
1.1
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
51
636
0.80
0.85
2.0
1.6
mg/l
3.9
3.9
0.01
39
455
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
109
938
1.17
0.85
1.7
1.9
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
13
80
1.63
0.84
1.0
1.1
u/ml
0.4
2.0
—
5
33
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1671
16430
1.09
0.82
4.8
4.3
mmol/l
1.4
1.5
13.39
1551
15077
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
58
1.73
0.79
1.7
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
187
2072
0.89
0.77
4.4
4.5
%
31.6
32.3
0.36
135
1404
(40762814) Titanium [Mass/volume] in Blood
0
28
0.00
0.76
0.0
2.2
—
3.0
—
0
12
(3020891) Body temperature
81
688
1.18
0.75
5.1
4.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
53
1.70
0.75
3.2
2.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
53
1.70
0.75
3.2
2.8
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
27
202
1.34
0.72
3.1
2.5
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
27
1.85
0.68
1.0
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
5
95
0.53
0.66
1.2
2.1
—
41.8
—
0
7
(3038177) Helicobacter pylori Ab [Presence] in Serum
32
250
1.28
0.65
1.3
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
56
667
0.84
0.65
1.8
1.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
29
1.73
0.64
1.2
1.3
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
23
172
1.34
0.63
1.1
1.0
u/ml
0.1
0.3
—
5
50
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
85
739
1.16
0.63
1.6
1.8
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
10
63
1.59
0.61
1.5
2.4
ug/l
1.2
1.6
—
10
58
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
164
1491
1.11
0.61
1.4
1.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
21
0.00
0.60
0.0
2.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
22
0.00
0.59
0.0
2.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
70
809
0.86
0.58
1.5
1.7
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
17
123
1.39
0.58
1.2
1.5
g/l
0.9
1.0
0.58
17
123
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
42
347
1.21
0.56
1.6
1.5
pmol/l
102.1
199.0
1.17
42
339
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
55
1.46
0.56
1.9
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
55
1.46
0.56
1.4
1.4
ug/l
10.0
9.0
—
8
55
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
28
221
1.27
0.55
1.6
1.4
u/l
29.8
24.1
0.35
21
182
(3003338) MCHC [Mass/volume]
1400
14243
0.95
0.55
38.5
18.4
g/l
330.0
332.5
17.58
1390
14129
(3027273) Bicarbonate [Moles/volume] in Venous blood
93
824
1.13
0.55
4.6
3.4
mmol/l
25.3
25.2
0.09
87
794
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
20
151
1.33
0.54
5.0
5.1
u/ml
16.5
57.6
—
7
47
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
49
577
0.85
0.53
2.1
1.8
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
39
1.54
0.53
2.2
3.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
50
428
1.17
0.48
4.6
4.3
—
—
—
0
0
(4281824)
21
164
1.28
0.46
1.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
49
1.43
0.46
1.3
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
8
117
0.68
0.46
1.0
1.0
ng/l
36.0
43.9
—
8
68
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
78
1.41
0.43
1.1
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
23
185
1.25
0.42
1.1
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
19
0.00
0.39
0.0
1.7
—
7.3
—
0
7
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
448
4645
0.95
0.37
4.0
4.3
%
22.7
21.5
0.96
222
2278
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
8
116
0.69
0.37
1.0
1.0
ng/l
282.1
298.5
—
8
70
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
197
1858
1.07
0.36
1.7
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
92
841
1.10
0.36
1.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
32
273
1.17
0.35
1.6
1.7
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
13
102
1.28
0.30
1.1
1.4
—
1.4
—
0
5
(3036071) Salmonella sp Ab [Titer] in Serum
8
62
1.29
0.28
1.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
56
508
1.11
0.28
1.5
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
590
5764
1.03
0.27
4.8
5.0
ug/l
4.2
2.9
0.27
526
5163
(3005570) Glucose [Moles/volume] in Urine
15
182
0.82
0.26
1.9
2.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
28
244
1.15
0.25
1.1
1.0
u/ml
5.2
2.6
—
7
106
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
9
72
1.25
0.25
1.1
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
33
371
0.89
0.24
1.3
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
82
0.73
0.24
1.2
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
24
208
1.16
0.24
3.6
2.4
mg/l
28.9
22.8
—
7
52
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
23
199
1.16
0.23
1.4
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
33
294
1.12
0.23
1.5
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
42
1.19
0.21
1.4
1.6
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
44.6
—
0
5
(3013762) Body weight Measured
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
48
1.25
0.20
1.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
34
307
1.11
0.20
1.6
1.6
—
—
—
0
0
(44806420)
6
49
1.23
0.20
2.7
2.5
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
12
100
1.20
0.18
1.7
1.8
mmol/l
7.3
7.6
—
7
60
(3045683) HLA typing for celiac disease panel - Blood or Tissue
11
91
1.21
0.17
1.0
1.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
57
533
1.07
0.17
4.8
4.1
mmol/l
4.0
3.9
0.54
49
498
(4146454)
15
173
0.87
0.16
2.1
2.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
34
370
0.92
0.16
1.1
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
14
124
1.13
0.11
1.0
1.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
23
211
1.09
0.11
1.3
1.3
mmol/l
6.7
7.5
0.47
17
150
(4094501)
49
466
1.05
0.10
1.1
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
45
1.11
0.09
1.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
330
3348
0.98
0.09
2.8
3.1
ug/l
0.8
0.8
0.08
224
2232
(3000034) Microalbumin [Mass/volume] in Urine
13
145
0.90
0.09
2.2
3.3
mg/l
46.7
35.5
—
7
111
(4015189)
5
48
1.04
0.09
1.6
2.5
—
—
—
0
0
(4024509)
14
155
0.90
0.09
2.1
1.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
74
1.08
0.07
1.5
1.9
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
19
176
1.08
0.07
2.3
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
84
0.83
0.07
1.7
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
9
86
1.05
0.07
1.0
1.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
88
1.02
0.07
1.2
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
11
99
1.11
0.06
7.8
7.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
364
3637
1.00
0.00
4.8
4.0
kg/l
1.0
1.0
0.33
50
524
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
2.4
—
0
8
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
212.6
—
0
5
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
77
0.91
0.00
2.0
2.4
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
32
320
1.00
0.00
1.4
1.6
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
2.4
—
0
6
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_OTHERWHITECELL and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_OTHERWHITECELL | 2.347 [2.09, 2.64] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.084 |
During the follow-up period (1.1.1998 — 31.12.2019), 1514 out of 5993 females with D3_OTHERWHITECELL died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_OTHERWHITECELL | 2.421 [2.12, 2.76] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 1770 out of 5506 males with D3_OTHERWHITECELL died.
Mortality risk
Mortality risk for people of age
years, who have D3_OTHERWHITECELL.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.184% | 0.514% |
| 5 | 1.121% | 2.821% |
| 10 | 3.172% | 6.665% |
| 15 | 6.287% | 12.13% |
| 20 | 10.342% | 20.488% |
Relationships between endpoints
↥Index endpoint: D3_OTHERWHITECELL – Other disorders of white blood cells
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data